NASDAQ:BCDA
BioCardia, Inc.
BioCardia, Inc.'s revenue fell 100.0% in fiscal 2025 to $0. Free cash flow was −$7.4M.Summary generated from BioCardia, Inc.'s SEC filings. Latest annual report filed Mar 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growth−100.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−950.1%
Debt / equityn/a
Free cash flow−$7.4M
FCF marginn/a
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 | 0 | 0 | 0 |
| Operating income | −13 | −12 | −12 | −8 | −8 |
| Net income | −13 | −12 | −12 | −8 | −8 |
| Free cash flow | −10 | −11 | −10 | −8 | −7 |
Recent filings
- 8-KOther events
Oct 7, 2026 - 8-KOther events
Oct 1, 2026 - 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Sep 23, 2026 - 8-KOther events
Sep 23, 2026 - 8-KOther events
Sep 21, 2026 - 8-KOther events
Sep 10, 2026 - 8-KRegulation FD disclosure
Aug 24, 2026